• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《TMR现代中药》 >The active ingredients of Huanglian Jiedu Decoction in treating COVID- 19 based on network pharmacology, molecular docking and molecular dynamics simulation

The active ingredients of Huanglian Jiedu Decoction in treating COVID- 19 based on network pharmacology, molecular docking and molecular dynamics simulation

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective:To explore the active ingredients of Huanglian Jiedu Decoction(HLJD)for the treatment of COVID-19 and to further verify the combination mode.Methods:The TCMSP database was used to search for HLJD active ingredients and targets.COVID-19 targets were collected from GeneCards,DisGeNET and OMIM databases.Material-active-ingredients-targets(gene)network and targets protein-protein interaction network were constructed using Cytoscape 3.8.0 and the STRING database.GO functional enrichment analysis and KEGG pathway enrichment analysis of core targets were performed using R software.Cytoscape 3.8.0 was used to build“compound-targets-pathways”to predict HLJD mechanisms,and active ingredients were used as ligands to molecularly dock with SARS-CoV-23CL hydrolase,Spike glycoprotein and ACE2.The binding energy was calculated by molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area method,and intermolecular interactions and the contribution of each residue to the binding free energy were analyzed.Results:Four medicinal materials,66 compounds and 219 targets were identified.It is found that the Protein-Protein Interaction core network contained 35 HLJD key targets proteins for COVID-19 treatment.705 GO functional enrichment entries(P<0.05)were produced;while KEGG pathway enrichment analysis identified 142 pathways(P<0.05)involving the Tumor Necrosis Factor signaling pathway and Interleukin-17 signaling pathway,etc.The binding energies of Kihadanin A,Palmidin A,Obacunone and Hispidone are much smaller than those of the currently reported clinical drugs with anti-SARS-CoV-2 drugs.The results of the binding energy indicate that van der Waals force is the main driving force for enzyme-substrate combination,whereas the electrostatic interaction and non-polar solvents contribute less.Conclusion:The“multi-component-multi-targets-multi-pathway”synergy of HLJD,which binds to SARSCoV-23CL hydrolase,Spike glycoprotein and ACE2,can act on targets Heat Shock Protein 90 Alpha Family Class A Member 1,Adrenoceptor Beta 2,Checkpoint Kinase 1,Peroxisome Proliferator-Activated Receptor Gamma and Mitogen-activated protein kinase 14 to regulate multiple signal pathways,and it may have a therapeutic effect on COVID-19.

著录项

  • 来源
    《TMR现代中药》 |2021年第1期|P.9-23|共15页
  • 作者

    Ping Xie; Xiaohan Jin; Yuanfa Lai; Chunli Hao; Huabin Huang; Shaogui He; Qihua You;

  • 作者单位

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian ChinaXiamen Key Laboratory of food and drug safety Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian ChinaXiamen Key Laboratory of food and drug safety Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian ChinaXiamen Key Laboratory of food and drug safety Xiamen 361024 Fujian China;

    College of Environment and Public Health Xiamen Huaxia University Xiamen 361024 Fujian ChinaBiochemical Pharmacy Engineering Research Center of Fujian Province University Xiamen 361024 Fujian ChinaXiamen Key Laboratory of food and drug safety Xiamen 361024 Fujian China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    Network pharmacology; Molecular docking; Molecular dynamics simulation; Huanglian Jiedu Decoction; COVID-19;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号